ArticleFrontiers in cardiovascular medicine2022

Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer.

Elizabeth J Rowe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.